Profil
Dr. Line Hartvig has spent more than ten years in the biotech and pharmaceutical industry.
She has a broad understanding of many phases in research and development of pharmaceuticals (small molecules, peptides and biopharmaceuticals).
She has been involved in the creation of new pipeline opportunities (proposal of new projects), compliance to tight project plans and goals, and filling of documentation to regulatory authorities.
Moreover she has experience in transfer of technologies to contract research organisations.
She has worked on numerous projects covering several molecular targets (e.g.
ligand/voltage-gated ion channels, gap junctions, G-protein coupled receptors, coagulation factors) in the fields of neuroscience, cardiology and haemostasis.
She holds a Master of Science degree in Biochemistry from University of Copenhagen and a PhD in molecular and cellular biology from University of Copenhagen and she speaks fluent Danish and English.
Anciens postes connus de Line Hartvig
| Sociétés | Poste | Fin |
|---|---|---|
Sunstone Capital A/S
 Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors. | Analyste en capital-investissement | 01/01/2010 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors. | Finance |
